drug

vinblastine

1 story · latest Nov 3, 2026

Follow vinblastine. Every new filing, FDA action, and trial change, in your feed and a morning email, each linked to its source.

Follow free for 14 daysNo card.

Status: Investigational
Trials: 1 registered trial in coverage

Relationships

Developed by AstraZeneca

Timeline

Arvinas reports Q3 2026 results, dosing starts in new HPK1 trial

Nov 3Quarterly updateARV-6723 Arvinas Inc.

Biotech intelligence from primary sources. Every story is an original summary of a public record, linked to its source. Not investment advice.

Terms Privacy hello@readthrough.news

readthrough is a product of JAMN Ventures, LLC.